Biogena Group Invest AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Cash & Equivalents	12.28	23	24.48	17.42
Cash & Short-Term Investments	12.28	23	24.48	17.42
Cash Growth	-46.62%	-6.06%	40.51%	-
Accounts Receivable	0	3.6	36.42	351.42
Other Receivables	1,412	1,316	1,123	893.21
Total Trade Receivables	1,412	1,320	1,159	1,245
Total Current Assets	1,424	1,343	1,183	1,262
Long-Term Investments	-	7,484	7,484	7,484
Other Long-Term Assets	33.68	32.4	31.86	2.4
Total Assets	8,941	8,859	8,699	8,748
Accounts Payable	-	0	1.05	94.73
Accrued Expenses	12.4	11.55	76.51	75.88
Other Current Liabilities	225.72	354.63	101.82	20.24
Total Current Liabilities	238.12	366.17	179.38	190.85
Total Liabilities	238.12	366.17	179.38	190.85
Common Stock	3,990	3,990	3,990	3,990
Additional Paid-in Capital	3,884	3,884	3,884	3,884
Retained Earnings	828.94	618.37	645.47	746.28
Shareholders' Equity	8,703	8,493	8,520	8,621
Total Liabilities & Equity	8,941	8,859	8,699	8,748
Net Cash (Debt)	12.28	23	24.48	17.42
Net Cash Growth	-46.62%	-6.06%	40.51%	-
Net Cash Per Share	3.08	5.76	6.13	4.37
Book Value	8,703	8,493	8,520	8,621
Book Value Per Share	2181.25	2128.48	2135.27	2160.53
Tangible Book Value	8,703	8,493	8,520	8,621
Tangible Book Value Per Share	2181.25	2128.48	2135.27	2160.53